The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7273855 B1

PDF
Full Text
Expired
Date of Patent:
Sep. 25, 2007

Filed:

Jul. 08, 2002
Applicant:

Eldon R. Jupe, Norman, OK (US);

Inventor:

Eldon R. Jupe, Norman, OK (US);

Assignee:

Oklahoma Medical Research Foundation, Oklahoma City, OK (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12P 21/63 (2006.01); C12N 5/00 (2006.01); C12N 15/00 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
Abstract

It has now been found that the introduction of single stranded oligonucleotides of DNA or RNA, particularly RNA transcribed from portions of wild type prohibitin 3'UTR, into tumors leads to arrested cell proliferation. Significant reduction in the size of primary tumors has been observed following direct administration of prohibitin 3′UTR RNA. Induction of systemic immunity, as evidenced by the disappearance of metastases as well as the lack of tumor growth in rechallenged animals following prohibitin RNA therapy, has been observed. Thus, wild type RNAs transcribed from portions of a prohibitin 3′UTR, or single stranded DNAs comprised of portions of a prohibitin 3′UTR, or synthetically-made oligonucleotides of the same sequences, can be directly administered as therapeutic agents against tumors.


Find Patent Forward Citations

Loading…